№ lp_1_2_35015
Year: 2024
Region / City: Massachusetts
Topic: Healthcare / Drug Coverage
Document Type: Newsletter
Organization / Institution: MassHealth
Author: MassHealth Drug Utilization Review Program and the MassHealth Pharmacy Program
Target Audience: Healthcare providers, MassHealth members
Period of Action: From October 2024 to January 2025
Approval Date: October 2024
Date of Changes: October 2024
Contextual Description: A newsletter detailing upcoming changes in MassHealth coverage for anti-obesity medications, including the introduction of Zepbound® (tirzepatide) as a preferred drug and updates to prior authorization requirements.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.